N'oge na-adịbeghị anya, JYMed Technology Co., Ltd. mara ọkwa na Leuprorelin Acetate, nke onye enyemaka ya na-emepụta Hubei JX Bio-Pharmaceutical Co., Ltd., agafewo nyocha nke ndebanye aha ọgwụ.
Nchịkọta ahịa ọgwụ izizi
Leuprorelin Acetate bụ ọgwụ injectable eji agwọ ọrịa ndị na-adabere na hormone, na usoro molecular C59H84N16O12•xC2H4O2. Ọ bụ gonadotropin na-ahapụ homonụ agonist (GnRHa) nke na-arụ ọrụ site na igbochi sistemu pituitary-gonadadal. Nke mbụ AbbVie na Takeda Pharmaceutical mebere ya, a na-ere ọgwụ a n'okpuru aha ika dị iche iche na mba dị iche iche. Na United States, a na-ere ya n'okpuru akara aha LUPRON DEPOT, ebe na China, a na-ere ya dị ka Yina Tong.
Usoro doro anya yana ọrụ akọwara nke ọma
Site na 2019 ruo 2022, emechara nyocha na mmepe ọgwụ, ndebanye aha API na Machị 2024, mgbe enwetara ọkwa nnabata. Emere nyocha ndebanye ọgwụ ọgwụ n'August 2024. JYMed Technology Co., Ltd bụ maka mmepe usoro, mmepe usoro nyocha, ọmụmụ adịghị ọcha, nkwenye nhazi, na nkwado usoro. Hubei JX Bio-Pharmaceutical Co., Ltd bụ onye na-ahụ maka mmepụta nkwado usoro, nkwado usoro nyocha, na ọmụmụ nkwụsi ike maka API.
Ịgbasawanye ahịa na ọchịchọ na-eto eto
Mmụba na-arịwanye elu nke ọrịa cancer prostate na fibroids uterine na-ebute mmụba nke Leuprorelin Acetate. Ahịa North America na-achịkwa ahịa Leuprorelin Acetate ugbu a, yana mmefu nlekọta ahụike na-eto eto na nnabata dị elu nke teknụzụ ọhụrụ bụ ndị na-ebu ibu na-eto eto. N'otu oge ahụ, ahịa Eshia, karịsịa China, na-egosipụtakwa ọchịchọ siri ike maka Leuprorelin Acetate. N'ihi ịdị irè ya, ọchịchọ zuru ụwa ọnụ maka ọgwụ a na-arị elu, yana nha ahịa a na-atụ anya iru $ 3,946.1 nde site na 2031, na-egosipụta ọnụego uto kwa afọ (CAGR) nke 4.86% site na 2021 ruo 2031.
Banyere JYMed
Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọ JYMed) e hiwere na 2009, ọkachamara na nyocha, mmepe, mmepụta na ahịa nke peptides na ngwaahịa ndị metụtara peptide. Site na otu ụlọ ọrụ nyocha na ntọala nrụpụta atọ, JYMed bụ otu n'ime ndị na-emepụta peptide API nke kemịkalụ na China. Ndị otu R&D nke ụlọ ọrụ ahụ na-anya isi ihe karịrị afọ 20 nke ahụmịhe na ụlọ ọrụ peptide ma gafere nyocha FDA ugboro abụọ. Sistemụ nrụpụta peptide zuru oke na nke ọma nke JYMed na-enye ndị ahịa ọrụ dị iche iche, gụnyere mmepe na mmepụta nke peptides ọgwụgwọ, peptides ọgwụgwọ anụmanụ, peptides antimicrobial, na peptides ịchọ mma, yana ndebanye aha na nkwado iwu.
Ihe omume azụmahịa isi
1.Nbanye na mba ndebanye aha nke peptide API
2.Veterinary na ịchọ mma peptides
3.Custom peptides na CRO, CMO, OEM ọrụ
4.PDC ọgwụ (peptide-radionuclide, peptide-obere molecule, peptide-protein, peptide-RNA)
Na mgbakwunye na Leuprorelin Acetate, JYMed etinyela akwụkwọ ndebanye aha na FDA na CDE maka ọtụtụ ngwaahịa API ndị ọzọ, gụnyere ọgwụ klas GLP-1RA na-ewu ewu ugbu a dị ka Semaglutide, Liraglutide na Tirzepatide. Ndị ahịa na-eji ngwaahịa JYMed n'ọdịnihu ga-enwe ike ịdebanye aha nọmba ndebanye aha CDE ma ọ bụ nọmba faịlụ DMF ozugbo mgbe ha na-enyefe ngwa ndebanye aha na FDA ma ọ bụ CDE. Nke a ga-ebelata nke ukwuu oge achọrọ maka ịkwadebe akwụkwọ ngwa, yana oge nyocha na ọnụ ahịa nyocha ngwaahịa.
Kpọtụrụ anyị
Shenzhen JYMed Technology Co., Ltd.
adreesị:8th & 9th Floor, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Ekwentị:+86 755-26612112
Weebụsaịtị:http://www.jymedtech.com/
Oge nzipu: Ọgọst-29-2024